Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
---|
05/23/2002 | CA2771909A1 Proteins producing an altered immunogenic response and methods of making and using the same |
05/23/2002 | CA2421182A1 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications |
05/22/2002 | CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use |
05/14/2002 | CA2249180C Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
05/02/2002 | EP1201137A1 Cysteine/glycine rich peptides |
04/30/2002 | US6379678 Culture product; antiallergens |
04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
04/24/2002 | CA2359606A1 Cysteine/glycine rich peptides |
04/18/2002 | WO2002030990A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
04/18/2002 | WO2002030987A1 Antihuman heme oxygenase-1 monoclonal antibody |
04/17/2002 | EP1196587A2 Antigenic meningococcal peptides |
04/17/2002 | CN1344723A High-purity biliprotein separating process |
04/11/2002 | WO2002012275A3 Lat peptides and their use in assays for identifying immunosuppressants |
04/11/2002 | WO2001074898A8 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
04/11/2002 | WO2001051011A3 Condensation products of proteins, whereby azelaic acid is used |
04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
04/09/2002 | US6368877 Self-assembling peptide surfaces for cell patterning and interactions |
03/28/2002 | US20020037834 Process control; low temperature |
03/27/2002 | EP1189623A2 Method and composition for inhibiting cardiovascular cell proliferation |
03/26/2002 | US6362371 β2- adrenergic receptor agonists |
03/19/2002 | US6359118 Carbohydrate crosslinked glycoprotein crystals |
03/14/2002 | WO2002019822A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
03/14/2002 | WO2001057066A3 Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin |
03/14/2002 | CA2421391A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
03/13/2002 | EP0673652B1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
03/12/2002 | US6355805 β3-adrenergic receptor agonists |
03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
03/06/2002 | CN1339063A Human hybrid host cell for mammalian gene expression |
02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
02/14/2002 | WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants |
02/13/2002 | CN1335323A Maggot protein |
01/31/2002 | WO2002008449A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
01/31/2002 | WO2001025794B1 Protein fingerprinting by multisite labelling |
01/31/2002 | US20020012948 Metallopeptide combinatorial libraries and applications |
01/31/2002 | CA2417134A1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
01/24/2002 | WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
01/23/2002 | CN1332176A Semi-dry microwave synthesis process of phosphoprotein |
01/17/2002 | WO2002004014A1 New class of bioactive glycoprotein |
01/17/2002 | CA2385142A1 New class of bioactive glycoprotein |
01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
01/08/2002 | CA2166198C Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
01/02/2002 | EP1165693A2 Squaraine dyes |
01/01/2002 | US6335457 Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex |
12/27/2001 | WO2001098522A2 Positively-charged peptide nucleic acid analogs with improved properties |
12/27/2001 | CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties |
12/19/2001 | EP1163337A2 Vascular adhesion molecules and modulation of their function |
12/13/2001 | WO2001094327A1 Catalyst comprising soluble polymer and polyamino acid |
11/29/2001 | US20010046680 Identification of polypeptides and nucleic acid molecules using linkage between DNA and polypeptide |
11/20/2001 | US6319693 Cloning of chicken anemia virus DNA |
11/15/2001 | WO2001086590A1 The use of proteinaceous molecules in methods for molecular computing |
11/15/2001 | CA2408545A1 The use of proteinaceous molecules in methods for molecular computing |
11/14/2001 | EP1154376A1 The use of proteinaceous molecules in methods for molecular computing |
11/08/2001 | WO2001083507A1 Identification of polypeptides and nucleic acid molecules using linkage between dna and polypeptide |
11/07/2001 | EP1151143A1 Selection of proteins using rna-protein fusions |
11/01/2001 | WO2000047775A9 Selection of proteins using rna-protein fusions |
10/30/2001 | US6310179 2-or 3-dimensional geometric structures |
10/25/2001 | WO2001025794A3 Protein fingerprinting by multisite labelling |
10/24/2001 | CN1318553A New affinity chromatography medium and purification method for cobra neurotoxin |
10/23/2001 | US6306612 Methods of facilitating vascular growth |
10/17/2001 | EP1143991A2 Inhibitors of h+k+ -atpase |
10/16/2001 | US6303322 Testing in multiplicity of wells; generating thermal unfolding or denaturation curve; combinatorial chemistry; receptor binding assay |
10/11/2001 | WO2001074898A2 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
10/11/2001 | CA2403537A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
10/10/2001 | EP1141375A1 Metallopeptide combinatorial libraries and applications |
10/10/2001 | EP1141272A1 Optical sorting method |
10/10/2001 | EP1141242A2 Oocyte activation by sperm components |
10/04/2001 | EP1137805A1 Methods of facilitating vascular growth |
10/04/2001 | EP1137768A1 Human hybrid host cell for mammalian gene expression |
10/04/2001 | EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
10/03/2001 | CN1315328A Protein resisting against plant mosaic virus |
10/02/2001 | US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1 |
09/20/2001 | WO2001068673A1 Oligonucleotide analogues, methods of synthesis and methods of use |
09/20/2001 | CA2402319A1 Oligonucleotide analogues, methods of synthesis and methods of use |
09/19/2001 | EP0948522A4 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
09/19/2001 | CN1313903A Compound and method for the prevention and/or the treatment of allergy |
09/19/2001 | CN1313290A Hydrolytic active substance of brain protein, its preparing process and its activity and sequence |
09/18/2001 | US6291192 Method for identifying conditions that facilitate recombinant protein folding |
09/18/2001 | US6291191 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization |
09/12/2001 | EP1131056A1 Particles based on polyamino-acid(s) and methods for preparing same |
09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
09/11/2001 | US6288055 Analgesic agents |
09/11/2001 | US6287761 Synthetic antigens for the detection of antibodies to hepatitis C virus |
09/11/2001 | CA2125175C New peptide derivatives |
08/30/2001 | WO2000074701A3 Method and composition for inhibiting cardiovascular cell proliferation |
08/30/2001 | US20010018191 Immunology complex with epitopes; Alzheimer's disease |
08/29/2001 | EP0547065B1 Melanin production by transformed microorganisms |
08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
08/16/2001 | WO1999064046A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
08/14/2001 | US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis |
08/14/2001 | US6274344 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides |
08/09/2001 | WO2001057066A2 Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin |
08/09/2001 | WO2001004316A3 Antigenic meningococcal peptides |
08/09/2001 | US20010012621 Determining the expression of lysyl oxidase, the expression of lysyl oxidase indicating that the compound is capable of suppressing ras functions |
08/09/2001 | CA2399231A1 Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin |
07/31/2001 | US6268218 Method for sensing and processing fluorescence data from multiple samples |
07/31/2001 | US6268158 Generating thermal denaturation curve |